Logo image of CMT

CORE MOLDING TECHNOLOGIES IN (CMT) Stock Fundamental Analysis

NYSEARCA:CMT - NYSE Arca - US2186831002 - Common Stock - Currency: USD

16.74  -0.11 (-0.65%)

After market: 16.74 0 (0%)

Fundamental Rating

6

Taking everything into account, CMT scores 6 out of 10 in our fundamental rating. CMT was compared to 85 industry peers in the Chemicals industry. CMT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. A decent growth rate in combination with a cheap valuation! Better keep an eye on CMT. With these ratings, CMT could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CMT was profitable.
In the past year CMT had a positive cash flow from operations.
In the past 5 years CMT has always been profitable.
CMT had a positive operating cash flow in each of the past 5 years.
CMT Yearly Net Income VS EBIT VS OCF VS FCFCMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

CMT's Return On Assets of 5.24% is fine compared to the rest of the industry. CMT outperforms 78.82% of its industry peers.
CMT has a better Return On Equity (7.82%) than 69.41% of its industry peers.
With a decent Return On Invested Capital value of 6.69%, CMT is doing good in the industry, outperforming 64.71% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CMT is above the industry average of 6.83%.
Industry RankSector Rank
ROA 5.24%
ROE 7.82%
ROIC 6.69%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
CMT Yearly ROA, ROE, ROICCMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

CMT has a better Profit Margin (4.10%) than 63.53% of its industry peers.
In the last couple of years the Profit Margin of CMT has grown nicely.
The Operating Margin of CMT (5.36%) is worse than 64.71% of its industry peers.
In the last couple of years the Operating Margin of CMT has grown nicely.
Looking at the Gross Margin, with a value of 18.11%, CMT is doing worse than 70.59% of the companies in the same industry.
CMT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.36%
PM (TTM) 4.1%
GM 18.11%
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
CMT Yearly Profit, Operating, Gross MarginsCMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

9

2. Health

2.1 Basic Checks

CMT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CMT has less shares outstanding
CMT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CMT has been reduced compared to a year ago.
CMT Yearly Shares OutstandingCMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CMT Yearly Total Debt VS Total AssetsCMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.00 indicates that CMT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.00, CMT belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
CMT has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
The Debt to FCF ratio of CMT (0.85) is better than 95.29% of its industry peers.
CMT has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.13, CMT belongs to the best of the industry, outperforming 87.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.85
Altman-Z 4
ROIC/WACC0.75
WACC8.91%
CMT Yearly LT Debt VS Equity VS FCFCMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.50 indicates that CMT has no problem at all paying its short term obligations.
CMT has a Current ratio of 2.50. This is in the better half of the industry: CMT outperforms 69.41% of its industry peers.
CMT has a Quick Ratio of 2.08. This indicates that CMT is financially healthy and has no problem in meeting its short term obligations.
CMT has a better Quick ratio (2.08) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.08
CMT Yearly Current Assets VS Current LiabilitesCMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

CMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.91%.
CMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.08% yearly.
CMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.46%.
Measured over the past years, CMT shows a small growth in Revenue. The Revenue has been growing by 1.24% on average per year.
EPS 1Y (TTM)-34.91%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-32.56%
Revenue 1Y (TTM)-34.46%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-21.37%

3.2 Future

The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
The Revenue is expected to grow by 1.48% on average over the next years.
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.31%
Revenue Next 2Y1.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CMT Yearly Revenue VS EstimatesCMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CMT Yearly EPS VS EstimatesCMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.13 indicates a correct valuation of CMT.
83.53% of the companies in the same industry are more expensive than CMT, based on the Price/Earnings ratio.
CMT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.46.
The Price/Forward Earnings ratio is 9.01, which indicates a very decent valuation of CMT.
87.06% of the companies in the same industry are more expensive than CMT, based on the Price/Forward Earnings ratio.
CMT is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.13
Fwd PE 9.01
CMT Price Earnings VS Forward Price EarningsCMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMT indicates a rather cheap valuation: CMT is cheaper than 94.12% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CMT indicates a rather cheap valuation: CMT is cheaper than 92.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.26
EV/EBITDA 4.6
CMT Per share dataCMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CMT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CMT may justify a higher PE ratio.
PEG (NY)0.85
PEG (5Y)N/A
EPS Next 2Y10.57%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CMT!.
Industry RankSector Rank
Dividend Yield N/A

CORE MOLDING TECHNOLOGIES IN

NYSEARCA:CMT (7/21/2025, 8:04:03 PM)

After market: 16.74 0 (0%)

16.74

-0.11 (-0.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-05 2025-08-05
Inst Owners68.59%
Inst Owner Change-0.11%
Ins Owners7.19%
Ins Owner Change3.72%
Market Cap155.01M
Analysts80
Price Target22.44 (34.05%)
Short Float %2.64%
Short Ratio6.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.5%
Min EPS beat(2)-100%
Max EPS beat(2)-12.99%
EPS beat(4)2
Avg EPS beat(4)3.52%
Min EPS beat(4)-100%
Max EPS beat(4)72.09%
EPS beat(8)5
Avg EPS beat(8)62.32%
EPS beat(12)8
Avg EPS beat(12)78.16%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-11.13%
Max Revenue beat(2)5.25%
Revenue beat(4)3
Avg Revenue beat(4)1.67%
Min Revenue beat(4)-11.13%
Max Revenue beat(4)11.57%
Revenue beat(8)4
Avg Revenue beat(8)-0.03%
Revenue beat(12)8
Avg Revenue beat(12)13.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.95%
Valuation
Industry RankSector Rank
PE 12.13
Fwd PE 9.01
P/S 0.54
P/FCF 6.26
P/OCF 4.28
P/B 1.03
P/tB 1.21
EV/EBITDA 4.6
EPS(TTM)1.38
EY8.24%
EPS(NY)1.86
Fwd EY11.1%
FCF(TTM)2.68
FCFY15.98%
OCF(TTM)3.91
OCFY23.34%
SpS30.85
BVpS16.18
TBVpS13.86
PEG (NY)0.85
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.24%
ROE 7.82%
ROCE 8.63%
ROIC 6.69%
ROICexc 8.93%
ROICexgc 10.66%
OM 5.36%
PM (TTM) 4.1%
GM 18.11%
FCFM 8.67%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
ROICexc(3y)11.4%
ROICexc(5y)9.43%
ROICexgc(3y)13.69%
ROICexgc(5y)11.53%
ROCE(3y)12.62%
ROCE(5y)10.78%
ROICexcg growth 3Y14.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y16.49%
ROICexc growth 5YN/A
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
F-Score7
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.85
Debt/EBITDA 0.67
Cap/Depr 85.61%
Cap/Sales 3.99%
Interest Coverage 12.98
Cash Conversion 126.39%
Profit Quality 211.33%
Current Ratio 2.5
Quick Ratio 2.08
Altman-Z 4
F-Score7
WACC8.91%
ROIC/WACC0.75
Cap/Depr(3y)98.69%
Cap/Depr(5y)85.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.23%
Profit Quality(3y)108.24%
Profit Quality(5y)132.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-34.91%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-32.56%
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.46%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-21.37%
Revenue Next Year1.31%
Revenue Next 2Y1.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.06%
EBIT growth 3Y17.56%
EBIT growth 5YN/A
EBIT Next Year107.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y173.66%
FCF growth 3Y189.18%
FCF growth 5Y20.65%
OCF growth 1Y43.08%
OCF growth 3Y40.98%
OCF growth 5Y16.05%